Ramipril

CAS Number: 87333-19-5

Molecular Formula: C23H32N2O5

About Ramipril

Ramipril (CAS 87333-19-5) serves as a cornerstone in the cardiovascular therapeutic sector, primarily specialized in treating hypertension and heart failure through the inhibition of angiotensin-converting enzyme (ACE) to promote vasodilation. As a leading bulk chemical supplier, we address the evolving needs of North ...

Ramipril Specifications

CAS Number

87333-19-5

Molecular Formula

C23H32N2O5

Molecular Weight

416.52 g/mol

IUPAC Name

(2S,3aS,6aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid

Canonical SMILES

CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@H]3CCC[C@H]3CC2C(=O)O

InChI Key

HDACQVRGBOVJII-JBDAPHQKSA-N

CAS Number

87333-19-5

Molecular Formula

C23H32N2O5

Molecular Weight

416.52 g/mol

IUPAC Name

(2S,3aS,6aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid

Canonical SMILES

CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@H]3CCC[C@H]3CC2C(=O)O

InChI Key

HDACQVRGBOVJII-JBDAPHQKSA-N

Molecular Weight

416.52 g/mol

Antihypertensive Agent

An angiotensin-converting enzyme (ACE) inhibitor used as a primary treatment for essential hypertension to lower blood pressure and prevent associated cardiovascular complications

Cardiovascular Risk Reductant

A therapeutic agent indicated to reduce the risk of myocardial infarction, stroke, and death in patients aged 55 and older with high cardiovascular risk factors

Heart Failure Medication

A clinical treatment used to improve survival and reduce the progression of heart failure in patients following a myocardial infarction

Nephroprotective Agent

A medication employed in the management of chronic kidney disease, including diabetic nephropathy, to slow the progression of renal damage and reduce proteinuria.